Artidis Ag
Clinical trials sponsored by Artidis Ag, explained in plain language.
-
Nanotech biopsy test aims to outsmart pancreatic cancer
Diagnosis Recruiting nowThis study is testing a new test called NEO-Match® that uses nanomechanical profiling to analyze biopsy samples from people with suspected pancreatic cancer. The goal is to see if the test can predict how well patients will respond to treatment and help doctors make better decisi…
Phase: NA • Sponsor: ARTIDIS AG • Aim: Diagnosis
Last updated May 17, 2026 00:46 UTC
-
Nanotech touch could revolutionize breast cancer diagnosis
Diagnosis Recruiting nowThis study is testing a new device called ARTIDIS that measures the stiffness of breast tissue to help diagnose cancer and predict how aggressive it might be. About 2,700 adults with suspicious breast lumps will have their biopsy samples tested with ARTIDIS, and results will be c…
Phase: NA • Sponsor: ARTIDIS AG • Aim: Diagnosis
Last updated May 14, 2026 12:02 UTC